Suchergebnisse - "Wong, Harvey"

PubPharm (193)

1

Quantitative Assessment of Drug Efficacy and Emergence of Resistance in Patients with Metastatic Renal Cell Carcinoma Using a Longitudinal Exposure-Tumor Growth Inhibition Model : Apitolisib (Dual PI3K/mTORC1/2 Inhibitor) Versus Everolimus (mTORC1 Inhibitor)

enthalten in: Journal of clinical pharmacology | 2024

von Moein, A. | Jin, J. | Wright, M. | +1

2

Neutrophil elastase as a versatile cleavage enzyme for activation of αvβ3 integrin-targeted small molecule drug conjugates with different payload classes in the tumor microenvironment

enthalten in: Frontiers in pharmacology | 2024

von Rebstock, A. | Wiedmann, M. | Stelte-Ludwig, B. | +5

3

Time-dependent clearance can confound exposure-response analysis of therapeutic antibodies : A comprehensive review of the current literature

enthalten in: Clinical and translational science | 2024

von Proctor, J. | Wong, H.

4

Time‐dependent clearance can confound exposure–response analysis of therapeutic antibodies : A comprehensive review of the current literature

enthalten in: Clinical and Translational Science | 2024

von Proctor, J. | Wong, H.

5

Enitociclib, a Selective CDK9 Inhibitor, Induces Complete Regression of MYC+ Lymphoma by Downregulation of RNA Polymerase II Mediated Transcription

enthalten in: Cancer research communications | 2023

von Frigault, M. | Mithal, A. | Wong, H. | +7

6

Discovery of VIP236, an αvβ3-Targeted Small-Molecule-Drug Conjugate with Neutrophil Elastase-Mediated Activation of 7-Ethyl Camptothecin Payload for Treatment of Solid Tumors

enthalten in: Cancers | 2023

von Lerchen, H. | Stelte-Ludwig, B. | Heroult, M. | +7

7

COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS FOR THE TREATMENT, PREVENTION, OR MANAGEMENT OF HYPERPROLIFERATIVE DISORDER

enthalten in: Europäisches Patentamt | 2023

von LERCHEN HANS-GEORG | STELTE-LUDWIG BEATRIX | WIEDMANN MAREIKE | +4

8

COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS FOR THE TREATMENT, PREVENTION, OR MANAGEMENT OF HYPERPROLIFERATIVE DISORDERS

enthalten in: Europäisches Patentamt | 2023

von LERCHEN HANS-GEORG | STELTE-LUDWIG BEATRIX | WIEDMANN MAREIKE | +3

9

COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS FOR THE TREATMENT, PREVENTION, OR MANAGEMENT OF HYPERPROLIFERATIVE DISORDER

enthalten in: Europäisches Patentamt | 2023

von LERCHEN HANS-GEORG | STELTE-LUDWIG BEATRIX | WIEDMANN MAREIKE | +4

10

COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS FOR THE TREATMENT, PREVENTION, OR MANAGEMENT OF HYPERPROLIFERATIVE DISORDERS

enthalten in: Europäisches Patentamt | 2023

von LERCHEN HANS-GEORG | STELTE-LUDWIG BEATRIX | WIEDMANN MAREIKE | +3

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[20]